Stockholders' Equity (Details) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended				3 Months Ended	12 Months Ended
	Sep. 10, 2021	Sep. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Nov. 30, 2022	Mar. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Oct. 31, 2024	Dec. 31, 2021
Stock issued (in dollars per share)		$ 55			$ 35
Payment of offering expenses		$ 400			$ 500
Proceeds from issuance of common stock		$ 235,800			$ 433,200
Research and development							$ 404,138	$ 320,678	$ 316,415
Preferred stock, shares authorized							50,000,000
Preferred stock, shares issued							0
Preferred stock, shares outstanding							0
Common stock, shares authorized							750,000,000	750,000,000
Common stock, par value (in dollars per share)							$ 0.0001	$ 0.0001
Common stock, shares issued		4,550,000			13,144,500		132,646,000	119,581,000		7,532,300
Common stock, shares outstanding							132,646,000	119,581,000
In-process research and development acquisition
Asset acquisition, consideration	$ 35,600		$ 15,000	$ 10,000
Issuance of common stock	276,346
Value of common stock issued	$ 30,900				$ 10,000	$ 15,000
Cash consideration	3,900
Net liabilities assumed	200
Acquisition related costs	600
Value of additional shares potentially issuable	$ 35,000
Number of additional shares potentially issuable	269,547
Common stock
Common stock, shares issued				111,255,000			132,646,000	119,581,000	111,255,000		95,140,000